ALISON SCHMITT: Open Payments
NPI 1265073134 · HIGHLANDS RANCH, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$443 in 13 payments from 5 companies in 2025. Trend: 2023 $453 · 2024 $342 · 2025 $443
Food & beverage: $443
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $141 |
| Otsuka America Pharmaceutical, Inc. | 1 | $118 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $108 |
| Lundbeck LLC | 4 | $61 |
| Biogen, Inc. | 1 | $15 |
Products named: REXULTI, CAPLYTA, TRINTELLIX, ZURZUVAE.
Industry payments across CO — which companies pay providers there.
